Navigation Links
NutraCea Provides Update on Domestic Operations
Date:1/28/2008

manufactures as well as distributes products and food ingredients made from Rice Bran through its proprietary technology and processes. The Company has developed intellectual properties to create a range of proprietary product formulations, delivery systems and whole food nutrition products. NutraCea's proprietary technology enables the creation of food and nutrition products from rice bran, normally a wasted by-product of standard rice processing. In addition to its whole foods products, NutraCea develops families of health- promoting "nutraceuticals," including natural arthritic relief and cholesterol-lowering products. More information can be found in the company's filings with the SEC and you can visit the NutraCea web site http://www.NutraCea.com

Forward Looking Statements

This release contains forward-looking statements, including, but not limited to, statements regarding the future completion of a new facilities, the continued operation of existing facilities, and the market demand from new accounts for the materials to be produced at the new and existing facilities, all of which statements are subject to market risks, and the possibility that NutraCea will not be able to complete the facilities on a timely basis, to continue the operations at existing facilities at full production levels, or to obtain sufficient customer demand to utilize expected production from the new and existing facilities. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties. The Company does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward- looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in
'/>"/>

SOURCE NutraCea
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NutraCea Forms Joint Ventures With HerbalScience to Develop Nutraceutical Extracts and Pharmaceutical Chemistries From Stabilized Rice Bran
2. NutraCea Announces Conference Call to Report Second Quarter Financial Results
3. NutraCea to Host Third Quarter 2007 Financial Results Conference Call November 14
4. NutraCea Appoints Financial Relations Board as New Investor Relations Firm
5. Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation
6. NJHA: State Report Provides Thorough Examination of Hospital Fiscal Woes
7. Enlarged Prostate Treatment Study Shows Combination of AVODART(R) and Tamsulosin Provides Greater Benefit Than Either Medication Alone
8. New Blog Provides Forum for Discussions on Supplement Safety
9. American HealthChoice CEO Dr. J.W. Stucki Provides Company Update
10. New pathway provides more clues about BRCA1 role in breast cancer
11. Stereotaxis Provides Fourth Quarter 2007 Revenue Outlook

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USNews...e following statement upon the United States Senat...e Health Care legislation: ,, "Senators Arlen S...lphians and all Pennsylvanians for casting stand-u...President Obama,s historic Affordable Health Care ...
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USN...1990s to eliminate onchocerciasis (river blindness...evalence of the disease in recent years, as eviden... requiring mass drug administration in six endemic...th annual meeting of the American Society of Tropi...
(Date:11/21/2009)... , HAPPYneuron,s most pop...ble on the iPhone and iPod Touch. , ...2009 -- HAPPYneuron,s most popular and addictive g...d iPod Touch. Split Words is designed to help bani...,The SplitWords iPhone brain game challenges the...
(Date:11/20/2009)... , , PRINCETON, NJ, Nov. 20 /PRNewswire-F...d today that a Special Meeting of Shareholders wil...e of the Meeting is to consider approval of two sp... to approve and authorize the sale of all or subst...ly on the terms provided for in the asset purchase...
(Date:11/20/2009)... , , MADISON, N.J., Nov. 20 /PRNewswire... influenza virus may have peaked in late October, ...tial source of illness in all age groups, includin...Diagnostics Incorporated (NYSE: DGX ), the world...tion and services. ,, In its most recent Quest...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...lligence could be defined as the capacity to perce...d those of others so as to be able to distinguish ...de for one,s thoughts and actions. One of the impo...tural world more effectively. , The Stress and He...
...side-Naive Chronic Hepatitis B e-Antigen (HBeAg) ...d One Patient with Genotypic Resi...ers Squibb Company,(NYSE: BMY ) today announced d...e amount of hepatitis B virus in the,blood, or vir...
...lar Instruments, Inc.,developer and manufacturer o...ressure-volume (P-V) systems, today announced the ...mall and large animal models. The MPVS Ultra simu... transgenic mice to domestic livestock. Using,the ...
..., Inc. (Nasdaq:,CRYO), a medical device company fo...ounced today the appointment of Mark Adams as Vice...s to CryoCor over 20 years,of cardiac related medi... which was approved by the FDA in August 2007,for ...
...Corporation (Nasdaq:,DNDN) will release its third ... 2007. Company management will host a conference c...ial results and provide a general,corporate update...tic) or +1-719-325-4876 (international) Webcast: ...
...2 Progen,Pharmaceuticals Limited (ASX: PGL; Nasda...nt Fast Track designation awarded to PI-88 for the...e resection of primary,liver cancer and in order t...has used the Special Protocol Assessment (SPA) pro...
Other Medicine News:Health News:Emotional Intelligence and the use of tobacco and cannabis 2Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 2Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 3Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 4Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 5Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 6Health News:Millar Instruments Launches Complete Pressure-Volume System for Large and Small Animal Models 2Health News:CryoCor Appoints New Vice President of Sales and Marketing 2Health News:CryoCor Appoints New Vice President of Sales and Marketing 3Health News:CryoCor Appoints New Vice President of Sales and Marketing 4Health News:-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET- 2Health News:Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 2Health News:Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 3
(Date:11/20/2009)...v. 20 Cornerstone Therap...utical company focused on acquiring, developing an...or the respiratory and related markets, today repo...e Food and Drug Administration ("FDA") alleging th... HCl 10 mg, Pyrilamine Maleate 16 mg) and Deconsal...
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ -- Landauer, In...he fiscal fourth quarter and full year of 2009 pre...mpany will host a conference call for investors on...ime. Investors may access the live call by dialing...), or 480-629-9835 (international callers), or by ...
(Date:11/20/2009)...a., Nov. 20 The Departm...shots to members of priority groups that did not h...of 18 clinics are being held statewide on Nov. 20-.... Hours on Saturday, Nov. 21, will be 8 a.m. to 2 ...from 2 p.m. to 8 p.m. ,, Individuals in the re...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2HealthyFeetStore com Celebrates 5th Anniversary 61506 1HealthyFeetStore com Celebrates 5th Anniversary 61506 2New HIMSS Analytics Survey Reveals Healthcare Business Associates Are Unprepared for Data Breach 61502 1New HIMSS Analytics Survey Reveals Healthcare Business Associates Are Unprepared for Data Breach 61502 2New HIMSS Analytics Survey Reveals Healthcare Business Associates Are Unprepared for Data Breach 61502 3Vivakor Inc Announces Stock Dividend 14870 1Vivakor Inc Announces Stock Dividend 14870 2Vivakor Inc Announces Stock Dividend 14870 3Vivakor Inc Announces Stock Dividend 14870 4
...(Nasdaq:,DNDN) will host a conference call today, ... to review the outcome of the interim analysis of ...oma Treatment, also known as D9902B),clinical tria...estigational,active cellular immunotherapy for the...interested may access the call with the following ...
...ewest study site, PHILADELPHIA, Oct. 3 The Child...ntract to manage a new study site in The,National ...local,participation, recruitment and data collecti...funded by the National Institutes of Health., Inv... in Burlington,County will participate in the stud...
Other Medicine Technology:Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2
1.0mm Trephine with Handle
3.5mm Trephine with Handle
8.0mm Calibrated Trephine Handle
7.25mm Calibrated Trephine Handle
Medicine Products: